Micafungin Pharmazac, 50 Mg

Micafungin, the active ingredient in Micafungin Pharmazac, 50 Mg, is an echinocandin presented as a 50 mg injectable solution for intravenous use. It treats invasive candidiasis, esophageal candidiasis, and is used for prophylaxis of Candida infections in hematopoietic stem cell transplantation.

GNH USA supplies Micafungin Pharmazac, 50 Mg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Micafungin is an echinocandin antifungal that inhibits fungal cell wall synthesis.

Invasive candidiasis: effective treatment of bloodstream and deep‑seated Candida infections. Esophageal candidiasis: resolves mucosal infection of the esophagus caused by Candida species. Prophylaxis of Candida infections in hematopoietic stem cell transplantation: prevents invasive candidiasis in high‑risk transplant recipients.

Micafungin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Elevated liver enzymes: transient increase in ALT or AST. - Infusion‑related reactions: flushing, rash, or mild hypotension during administration. - Fever: mild to moderate temperature rise. - Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hepatic dysfunction: marked elevation of liver enzymes or hepatitis. - Anaphylaxis: acute allergic reaction with respiratory distress or hypotension. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: acute kidney injury in susceptible patients.

When using Micafungin, clinicians should observe several safety measures. - Liver function monitoring: assess baseline and periodic ALT/AST levels. - Renal function assessment: evaluate creatinine clearance before and during therapy. - Drug interactions: review concomitant medications that affect hepatic metabolism. - Pregnancy and lactation: use only if benefit outweighs potential risk, as safety data are limited. - Patient selection: avoid in patients with known hypersensitivity to echinocandins. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with other medicines, requiring attention to the interaction strength.

Major Interactions (Avoid): - Cytochrome P450 inducers (e.g., rifampin, carbamazepine): may reduce micafungin exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase micafungin levels, raising toxicity risk. - Concurrent use with other echinocandins: additive toxicity, not recommended.

Moderate Interactions (Monitor Closely): - Immunosuppressants (e.g., tacrolimus, cyclosporine): monitor drug levels as micafungin may affect metabolism. - Antifungal agents with overlapping toxicity (e.g., amphotericin B): watch for hepatic or renal adverse effects. - Concomitant use with warfarin: monitor INR as micafungin may alter anticoagulant effect.